Qi Liu

Title: **Innovator Qi Liu: Pioneering RNA Editing**

Introduction

Qi Liu, an esteemed inventor based in Wuhan, China, has made significant contributions to the field of RNA editing through his groundbreaking work. With a focused mind and a passion for innovation, Liu has developed a patent that showcases his expertise and creativity in molecular biology.

Latest Patents

Liu holds a patent titled "Application of prokaryotic Argonaute protein with only RNA target cleavage activity in RNA editing." This innovative application provides a prokaryotic Argonaute protein that exclusively exhibits cleavage activity on target ribonucleic acid (RNA) during the RNA editing process. Derived from mesophilic prokaryotes, the protein boasts an amino acid sequence detailed in SEQ ID NO: 1 or consists of a highly similar protein with analogous functions. Notably, this protein demonstrates binding activity to single-stranded guide DNA and exhibits nuclease activity solely towards target RNA that is complementarily paired with the guide DNA. Consequently, this invention opens doors for in vitro and in vivo targeted RNA editing, marking a formidable advancement in the realm of genetic engineering.

Career Highlights

Qi Liu is affiliated with Hubei University, where his innovative research continues to influence the scientific community. His dedication to advancing biotechnological applications has positioned him as a leading figure in the field, offering solutions that enhance our understanding of RNA functions and editing mechanisms.

Collaborations

Throughout his career, Liu has collaborated with notable colleagues, including Lixin Ma and Yang Liu. These partnerships foster a dynamic research environment, leading to continued advancements and breakthroughs in RNA editing technologies.

Conclusion

In summary, Qi Liu stands out as an innovative inventor whose work in RNA editing is poised to make a lasting impact on biochemistry and genetic research. His patent represents a significant step forward in the development of targeted RNA editing tools, highlighting his role as a visionary in the scientific community.